The Memory Disorders Program is currently recruiting for the following studies.
|Recruiting||DOD-ADNI: A Study of Brain Aging in Vietnam War Veterans||ADCS|
|Recruiting||Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease||Georgetown University|
|Recruiting||221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (ENGAGE)||Biogen MA Inc.|
|Recruiting||A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GENERATION1)||Novartis|
|Recruiting||Memory Improvement Through Nicotine Dosing (MIND) Study (MIND)||ATRI|
|Recruiting||An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia (EARLY) (A5)||Janssen|
|Recruiting||Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol (ADNI3)||ATRI|
For information on participating in our recruiting studies, please see the main Research page.